Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034176
Filing Date
2025-03-06
Accepted
2025-03-06 07:40:25
Documents
85
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnmd-20241231.htm   iXBRL 10-K 2936369
2 EX-4.1 mnmd-ex4_1.htm EX-4.1 10647
3 EX-19.1 mnmd-ex19_1.htm EX-19.1 84794
4 EX-23.1 mnmd-ex23_1.htm EX-23.1 3362
5 EX-31.1 mnmd-ex31_1.htm EX-31.1 17662
6 EX-31.2 mnmd-ex31_2.htm EX-31.2 17653
7 EX-32.1 mnmd-ex32_1.htm EX-32.1 9876
8 EX-32.2 mnmd-ex32_2.htm EX-32.2 9916
9 GRAPHIC img174750837_0.jpg GRAPHIC 4996
10 GRAPHIC img195207284_0.jpg GRAPHIC 1156069
  Complete submission text file 0000950170-25-034176.txt   13495803

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnmd-20241231.xsd EX-101.SCH 1603344
88 EXTRACTED XBRL INSTANCE DOCUMENT mnmd-20241231_htm.xml XML 1707600
Mailing Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007 212-220-6633
Mind Medicine (MindMed) Inc. (Filer) CIK: 0001813814 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40360 | Film No.: 25713631
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)